Pages that link to "Q35682900"
Jump to navigation
Jump to search
The following pages link to Targeting melanocortin receptors as a novel strategy to control inflammation. (Q35682900):
Displaying 50 items.
- Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone (Q21558407) (← links)
- Evolution at two levels: on genes and form (Q21563630) (← links)
- Women with red hair report a slightly increased rate of bruising but have normal coagulation tests (Q24539145) (← links)
- The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature (Q24632057) (← links)
- Circadian Clocks, Stress, and Immunity (Q26747470) (← links)
- Melanocortin peptides: potential targets in systemic lupus erythematosus (Q26865343) (← links)
- Antimicrobial peptides for therapeutic applications: a review (Q27004635) (← links)
- Melanocortin receptor accessory proteins in adrenal disease and obesity (Q27013622) (← links)
- Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip (Q27316911) (← links)
- Both MC1 and MC3 Receptors Provide Protection From Cerebral Ischemia-Reperfusion-Induced Neutrophil Recruitment (Q27342543) (← links)
- Biphasic effect of melanocortin agonists on metabolic rate and body temperature (Q28243089) (← links)
- Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies (Q30275904) (← links)
- Body pigmentation as a risk factor for the formation of intracranial aneurysms (Q30436030) (← links)
- Immunotherapies for Immune-Mediated Myopathies: A Current Perspective (Q30699742) (← links)
- Re-evaluating the treatment of acute optic neuritis (Q30865447) (← links)
- New melanocortin 1 receptor binding motif based on the C-terminal sequence of alpha-melanocyte-stimulating hormone (Q33260352) (← links)
- Adrenocorticotropic hormone versus methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trial (Q33589934) (← links)
- Hormones and Neuropeptide Receptor Heteromers in the Ventral Tegmental Area. Targets for the Treatment of Loss of Control of Food Intake and Substance Use Disorders (Q33689876) (← links)
- Identification of candidate genes for dyslexia susceptibility on chromosome 18. (Q33742226) (← links)
- Melanocortin 1 receptor agonists reduce proteinuria (Q34117792) (← links)
- The melanocortin 3 receptor: a novel mediator of exercise-induced inflammation reduction in postmenopausal women? (Q34497036) (← links)
- Treatment of moderately to severely active systemic lupus erythematosus with adrenocorticotropic hormone: a single-site, open-label trial (Q34512800) (← links)
- Effect of NDP-α-MSH on PPAR-γ and -β expression and anti-inflammatory cytokine release in rat astrocytes and microglia (Q34612008) (← links)
- Neuroanatomical distribution of the melanocortin-4 receptors in male and female rodent brain (Q34660287) (← links)
- Novel α-MSH peptide analogues with broad spectrum antimicrobial activity (Q34692222) (← links)
- Functional evaluation of THIQ, a melanocortin 4 receptor agonist, in models of food intake and inflammation (Q34715986) (← links)
- Single administration of tripeptide α-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis after experimental traumatic brain injury in mice (Q34936711) (← links)
- ACTH gel in the treatment of multiple sclerosis exacerbation: a case study (Q34969795) (← links)
- Physiological roles of the melanocortin MC₃ receptor. (Q34984895) (← links)
- MC1R, eumelanin and pheomelanin: their role in determining the susceptibility to skin cancer (Q34988063) (← links)
- Central Nervous System Agents for Ischemic Stroke: Neuroprotection Mechanisms (Q35137635) (← links)
- α-Melanocyte stimulating hormone treatment in pigs does not improve early graft function in kidney transplants from brain dead donors (Q35146704) (← links)
- The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function (Q35168221) (← links)
- Repository corticotropin injection in a patient presenting with focal segmental glomerulosclerosis, rheumatoid arthritis, and optic neuritis: a case report (Q35219562) (← links)
- Melanocortin 4 receptor activation protects against testicular ischemia-reperfusion injury by triggering the cholinergic antiinflammatory pathway (Q35223049) (← links)
- Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis (Q35629987) (← links)
- Crucial role of the melanocortin receptor MC1R in experimental colitis (Q35760868) (← links)
- Inflammatory resolution: new opportunities for drug discovery (Q35770168) (← links)
- The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. (Q36003378) (← links)
- Functions of DPLIY motif and helix 8 of human melanocortin-3 receptor. (Q36006349) (← links)
- The MC4 receptor and control of appetite (Q36054459) (← links)
- Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways (Q36105389) (← links)
- Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists (Q36111675) (← links)
- An overview of the effects of annexin 1 on cells involved in the inflammatory process (Q36165863) (← links)
- Current options for the treatment of optic neuritis (Q36173222) (← links)
- The renaissance of corticotropin therapy in proteinuric nephropathies (Q36520242) (← links)
- α-Melanocyte-stimulating hormone regulates vascular NO availability and protects against endothelial dysfunction (Q36529028) (← links)
- Treatment of acute relapses in multiple sclerosis (Q36568671) (← links)
- Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis (Q36613389) (← links)
- Role of the melanocortin system in inflammation (Q36631438) (← links)